News
SMA Trial
Cross over randomised intrathecal zolgensma study for children with SMA2.
Site: Red Cross Muscle service
Study group: confirmed SMA2 between 2-18years of age.
Significant inclusion / exclusion criteria.
Sponsors will support travel costs for families not based in CT.
If you have a possible child who could qualify please email jo.wilmshurst@uct.ac.za.